Compound Detail
CHEMBL813
EPROSARTAN 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL813 |
| Name | EPROSARTAN |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | OROAFUQRIXKEMV-LDADJPATSA-N |
| Therapeutic | ✓ Yes |
8
Targets
14
Activities
1
Assay Types
13
PK Parameters
20
Publications
5
Known Names
5
Indications
Molecular Properties
424.5
MW (Da)
4.74
ALogP
5
HBA
2
HBD
92.4
PSA (Ų)
0.46
QED
0
Ro5 Violations
10
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1997 |
| Availability | Discontinued |
| Chirality | Achiral |
Indications
Cardiovascular Diseases Essential Hypertension Severe Acute Respiratory Syndrome Severe Acute Respiratory Syndrome Kidney Diseases
ATC Classification
C09CA02
eprosartan
Level 1: CARDIOVASCULAR SYSTEM
Level 2: AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
Activity Summary
IC50 14 meas. best 9.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Angiotensin II receptor CHEMBL2094112 | IC50 | 9.0 | 7.72 | 1.0 | 2 |
| Angiotensin II receptor (AT-1) type-1 CHEMBL2094250 | IC50 | 9.0 | 8.62 | 1.0 | 3 |
| Type-2 angiotensin II receptor CHEMBL257 | IC50 | 9.0 | 9.0 | 1.0 | 1 |
| Type-1 angiotensin II receptor B CHEMBL263 | IC50 | 9.0 | 9.0 | 1.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 8.82 | 7.0967 | 1.5 | 3 |
| Type-1 angiotensin II receptor CHEMBL227 | IC50 | 8.7 | 8.42 | 2.0 | 2 |
| ATP-binding cassette sub-family C member 3 CHEMBL5918 | IC50 | 5.18 | 5.18 | 6650.0 | 1 |
| ATP-binding cassette sub-family C member 2 CHEMBL5748 | IC50 | 4.24 | 4.24 | 57900.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 1.9 | mL.min-1.kg-1 | Homo sapiens |
| CL | 1.2 | mL.min-1.kg-1 | Homo sapiens |
| CL | 1.9 | mL.min-1.kg-1 | Homo sapiens |
| CL | 1.9 | mL.min-1.kg-1 | Homo sapiens |
| F | 13.0 | % | Homo sapiens |
| Fu | 0.017 | - | Homo sapiens |
| Fu | 0.017 | - | Homo sapiens |
| MRT | 1.5 | hr | Homo sapiens |
| T1/2 | 1.417 | hr | Rattus norvegicus |
| T1/2 | 5.0 | hr | - |
| T1/2 | 7.0 | hr | Homo sapiens |
| T1/2 | 2.1 | hr | Homo sapiens |
| Vd | 0.16 | L.kg-1 | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine